▶ Explore this week’s Tape — live, sortable, drill-down →

Good News, Sold: The AI Buildout’s First Bill Came Due

Every capital cycle has the same tell. It is not the day the spending stops. It is the day the market stops clapping for it — when a company does exactly what it promised and the stock falls anyway. This week the most expensive trade on earth hit that day three times.

Oracle delivered the backlog it told everyone it would deliver. A six-hundred-thirty-eight-billion-dollar pile of contracted future revenue, up more than three-and-a-half times in a year.¹ Cloud infrastructure revenue up ninety-three percent.² It did the thing. The stock fell ten percent.³

For two years the AI trade was a referendum on demand: is it real, how big, how fast. The bull won that argument. So the market moved the goalposts, the way it always does at this point in a buildout — from is the demand there to who pays to meet it, and what does the bill do to the balance sheet carrying it. Bill Maris said the quiet part on All-In this week: a trillion dollars of spend commitments sitting on sixty billion of revenue, and now you go to the public markets and hope retail picks up the difference.⁴ That is the bear case in one sentence. Three names walked straight into it this week, and the interesting part is that each of them is paying the bill a different way.

Oracle is borrowing it. Trailing free cash flow is already negative — they spent the better part of fifty billion dollars on capex to build the capacity behind that backlog, and the money to fund the next leg is coming out of the debt market into a tape that has stopped rewarding capital plans.⁵ NextEra is diluting for it. The biggest bet in the history of regulated utilities — a sixty-seven-billion-dollar, all-stock takeover of Dominion, built explicitly to wire thirty gigawatts of data-center power by twenty-thirty-five, Google and Meta already signed.⁶ All-stock is the tell. A utility already carrying sixteen times debt to free cash flow cannot borrow its way to the biggest deal in its sector’s history, so it is paying with equity and handing the cost to the shareholder it already has.⁷ The stock fell nine percent.⁸ Micron is the one name pre-selling it: its entire next fiscal year of high-bandwidth memory is already spoken for, certified into Nvidia’s roadmap, the demand contracted before the capacity ships.⁹

Three funding strategies — debt, equity, pre-sold demand — and one underlying wager: that AI demand is durable enough to convert all of it to cash before the interest comes due. The cashflow read is in Marcus’s column below; short version, two of these three have no multiple to quote because the denominator is still negative. Page one of the Cash Flow Memo this week is a capex ledger, not an earnings sheet.

This is what the back half of a capital cycle looks like, and it rhymes. The railroads, the fiber glut, the shale decade — the capital cycle never turns when the building stops. It turns when the market stops paying for the announcement and starts pricing the lag between the spend and the cash. The demand did not get worse this week. The accounting for it did.

The next data point is dated. Micron reports Wednesday the twenty-fourth.¹⁰ On the screen it trades at a hundred times trailing free cash flow, which sounds insane and tells you nothing — that is trough cash flow at the bottom of a memory cycle. Price it forward and consensus has it at a single-digit multiple of next year’s earnings,¹¹ with trailing cash flow already up more than five-fold off the low.¹² The test is not the headline print. It is whether the forward demand the whole buildout is leaning on shows up in one company’s order book. If Micron’s guide confirms, the bill looks affordable. If it wobbles, the cycle just got more expensive for all three.

Wall Street’s consensus on the AI buildout: too crowded, too expensive, too late. The stocks fell this week not because the demand soured — because the market finally started counting the cost. That is not the top. That is the capital cycle clearing its throat.

The Tape — W2624

Universe of 94 cashflow-memo names, snap dates 2026-06-05 → 2026-06-15. Composite is rank-sum percentile of FCF Yield + NTM Revenue Growth (higher = better balance). Banks and finance-book names shown separately.

Telltales Yield — Top 10

From the Cashflow Desk — Marcus Graham

Healthcare spent the week getting repriced by Washington, and the screens are tarring the whole sector with one brush. Regeneron is the name that brush gets wrong. It sits near the top of the board at 11.3x EV/FCF on an 8.8% free cash flow yield — cheaper than UnitedHealth, with no federal prosecutor auditing the numerator. That is the distinction the table cannot draw: UNH’s cash engine is the thing the DOJ is investigating; Regeneron’s is a drug franchise nobody has subpoenaed. Same sector, same de-rate, two completely different reasons for the cheap — one is cheap because the cash might be fiction, the other because it shares a GICS code with the one that might be. The test on the next print is whether biosimilar pressure on the franchise shows up in the cash line, or the de-rate was just guilt by association.

Telltales Yield — Bottom 10

This Week’s Reporters

Sector Medians

Debt / FCF Watch (highest leverage on TTM FCF)

Weekly Price Movement

Top 5 (week-over-week price)

Bottom 5 (week-over-week price)

Banks (shown separately — FCF metric not meaningful)

Finance-book — FCF not comparable

Customer-float / captive-finance / reserve businesses (IBKR broker float, KMX CarMax Auto Finance, PYPL customer funds, CRCL stablecoin reserves). The memo’s operating-FCF method overstates their FCF, so they are held off the ranked leaderboard pending the P&L-waterfall rebuild.

Data Gaps

90 of 90 ranked-eligible names ranked. 0 dropped for missing FCF yield or NTM revenue growth; 7 shown separately (banks + finance-book, FCF not comparable).

Source: cashflow-memo master_2026-06-15.csv. NTM growth from FMP analyst-estimates consensus. Composite is a percentile rank, not a recommendation.

The Issue — This Week's Brief

The Cashflow Memo

When Cheap Stopped Being Safe

The week being cheap stopped being safe, and the AI buildout kept spending anyway.

The Telltales Weekend Update. Ava Cabot and analyst Marcus Graham walk through what happened this week — and what’s coming next — across the universe of the Cash Flow Memo. About 13 minutes. No filler.

Download the memo at telltales.us. Hunt, Jason, and Mike are back Wednesday on episode 2625.

Chapter markers

* Time | Segment

* 0:15 | Cold open

* 0:55 | Theme — the AI buildout’s bill: Oracle, NextEra, Micron

* 5:10 | Deep dive — UnitedHealth vs CarMax

* 9:25 | Rapid-fire — Moderna, Intel

* 11:30 | Close + Consensus Watch

Full transcript

Opening disclaimer

Ava: The following conversation is intended for informational purposes only. You should always do your own work to determine if an investment is suitable for you.

Cold open

Ava: You’re listening to the Telltales Weekend Update. I’m Ava Cabot.

Marcus: And I’m Marcus Graham — the cashflow desk.

Ava: Quick note: the show is produced entirely with AI tools, and both voices you’re hearing are AI-generated. Send feedback through the Substack. We’re still early — this is a pilot, and we want to hear what’s working.

Ava: Here’s the week. Being cheap stopped being safe. The cheapest large-cap in healthcare spent the week with a federal prosecutor at the door. The retail name everyone screens as cheap is being handed customers by a tariff. And while the market was busy repricing the cheap stuff, the most expensive trade on earth — the AI buildout — just kept writing bigger and bigger checks, and got punished for it anyway. On Wednesday’s main show, episode 2624, Hunt, Jason, and Mike worked through the economics of that buildout — the data centers, and the sheer physics of powering them.[^ep-e2624] We’re going to put the cashflow lens on the bill. Because this was the week the bill started showing up in three different places at once.

Theme — the AI buildout’s bill

Ava: Start with the most expensive trade in the market, because this week it got complicated. For two years the AI story was demand — is it real, how big, how fast. This week the question flipped to cost. Who delivers it, who powers it, and whose balance sheet carries it. And here’s the contrarian note hanging over the whole thing: as Bill Maris put it on All-In this week, quote, ...